Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 11 September 2024, 10:42 HKT/SGT
Share:
    

Source: TR Capital
TR Capital Announces Appointment of Fourth Partner in Drive for Accelerated Growth

- Deepanshu Madan, an Indian national with experience across India and Southeast Asia, becomes the latest partner at Asia’s leading secondary private equity firm

- TR’s India business continues to expand and to capture growing opportunities as one of the first-movers in this space

Singapore and Mumbai, Sept 11, 2024 - (ACN Newswire) - TR Capital, the leading Asian secondary private equity firm, is pleased to announce that Deepanshu Madan has been made the firm’s fourth Partner, marking an important milestone in the firm’s strategic growth.

Deepanshu joined TR Capital seven years ago as a Director, and has since played a pivotal role in the development of the firm’s retail and healthcare portfolio across Asia. In November 2023, he was appointed as the Chief Executive Officer of one of the firm’s portfolio companies, Pharmacity, in Vietnam. At Pharmacity, he is implementing a thorough redesign of the business model to return it to sustainable profitability.

Paul Robine, Founder and CEO of TR Capital, said, “I am thrilled to welcome Deepanshu as our fourth Partner. His exemplary track record over the past seven years, including his exceptional contributions at Pharmacity, underscores the effectiveness of TR’s active investment approach.”

Deepanshu Madan, Partner at TR Capital, said, “I am pleased to be appointed as a Partner at TR Capital and to contribute to the strong investment and ownership culture at the firm. We will continue to push boundaries in developing and supporting our portfolio companies whilst delivering on our active investment approach.”

This new addition to TR Capital’s senior leadership team is a strategic move to bolster the firm’s expansion in key markets, particularly in India. Recent initiatives, including leading the innovative Samara Capital continuation fund and the Fibe secondary direct deal, highlight TR's commitment to advancing its market presence.

In accordance with its growth strategy, TR Capital has recently realigned its local teams at the Director and VP levels to ensure it remains attuned to the dynamics of each local market.

Mr. Robine further commented, “The global secondary market landscape is evolving rapidly, particularly in India, where smaller secondary funds are surfacing alongside established players like TR Capital, creating an increasingly dynamic industry. As a pioneer in this sector, we take great pride in our innovative contributions to the Indian market and look forward to continued success in the future.”

About TR Capital

TR Capital is a leading secondary private equity investor in the Asia-Pacific region, providing liquidity solutions to owners of private equity assets through single asset and portfolio transactions. 

The firm makes significant investments in innovative leaders in the Technology, Next-Generation Consumer and Healthcare sectors across Asia. TR Capital is an active investor and shareholder and works with its portfolio companies to optimize their business models and capital structures. 

TR Capital currently manages funds with aggregate capital commitments of close to US$1.5 billion. The firm’s sophisticated investor base includes sovereign funds, pension funds, asset management firms, entrepreneurs, and family offices.

For more information, please contact:

Artemis Associates

Diana Footitt, CEO

diana.footitt@artemisassociates.com

+852 9183 0667

Dan Bradley, Managing Director

dan.bradley@artemisassociates.com

+852 6145 7455

Bowen Chui, Director

bowen.chui@artemisassociates.com

+852 9783 0643

 




Topic: Press release summary
Source: TR Capital

Sectors: Funds & Equities
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms  
Monday, December 1, 2025 10:04:00 PM
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials  
Monday, December 1, 2025 9:43:00 PM
GMG Launches Pre-Order Sales for First to Market Multi Language THERMAL-XR(R) Kit with Electric Spray Gun  
Dec 1, 2025 21:29 HKT/SGT
Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology  
Monday, December 1, 2025 9:14:00 PM
HashKey Passes HKEX Hearing: From Asia's Compliance Pioneer to a Global Institutional Gateway for Digital Assets  
Dec 1, 2025 18:39 HKT/SGT
AcroMeta Announces Strategic Joint Venture to provide AI-Powered Global Trade Operating System  
Dec 1, 2025 18:20 HKT/SGT
FG Gold, AFC and Afreximbank Reach Financial Close on US$330 Million Senior Debt Financing for Baomahun Gold Project  
Dec 1, 2025 17:09 HKT/SGT
China Chunlai Announces 2025 Annual Results  
Dec 1, 2025 09:53 HKT/SGT
USDKG launching: $50M Gold-backed Stablecoin in the Kyrgyz Republic  
Nov 29, 2025 23:00 HKT/SGT
Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan  
Friday, November 28, 2025 10:00:00 PM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: